LUNG FY 2022 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$54M+10.8% YoY

Gross Profit

$40M74.3% margin

Operating Income

-$59M-109.3% margin

Net Income

-$59M-109.8% margin

EPS (Diluted)

$-1.59

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$46M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$194M

Total Liabilities

$40M

Stockholders' Equity

$154M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$48M	+10.8%
Gross Profit	$40M	$36M	+11.9%
Operating Income	-$59M	-$47M	-24.0%
Net Income	-$59M	-$49M	-21.1%